GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Vietnamese Biotech Inc (HSTC:AMV) » Definitions » Gross Profit

American Vietnamese Biotech (HSTC:AMV) Gross Profit : ₫0.00 Mil (TTM As of . 20)


View and export this data going back to 2009. Start your Free Trial

What is American Vietnamese Biotech Gross Profit?

American Vietnamese Biotech's gross profit for the three months ended in . 20 was ₫0.00 Mil. American Vietnamese Biotech's gross profit for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. American Vietnamese Biotech's gross profit for the three months ended in . 20 was ₫0.00 Mil. American Vietnamese Biotech's Revenue for the three months ended in . 20 was ₫0.00 Mil. Therefore, American Vietnamese Biotech's Gross Margin % for the quarter that ended in . 20 was N/A%.

American Vietnamese Biotech had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage


American Vietnamese Biotech Gross Profit Historical Data

The historical data trend for American Vietnamese Biotech's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Vietnamese Biotech Gross Profit Chart

American Vietnamese Biotech Annual Data
Trend
Gross Profit

American Vietnamese Biotech Quarterly Data
Gross Profit

Competitive Comparison of American Vietnamese Biotech's Gross Profit

For the Biotechnology subindustry, American Vietnamese Biotech's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Vietnamese Biotech's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Vietnamese Biotech's Gross Profit distribution charts can be found below:

* The bar in red indicates where American Vietnamese Biotech's Gross Profit falls into.



American Vietnamese Biotech Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

American Vietnamese Biotech's Gross Profit for the fiscal year that ended in . 20 is calculated as

Gross Profit (A: . 20 )=Revenue - Cost of Goods Sold
= -
=0.00

American Vietnamese Biotech's Gross Profit for the quarter that ended in . 20 is calculated as

Gross Profit (Q: . 20 )=Revenue - Cost of Goods Sold
= -
=0.00

Gross Profit for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

American Vietnamese Biotech's Gross Margin % for the quarter that ended in . 20 is calculated as

Gross Margin % (Q: . 20 )=Gross Profit (Q: . 20 ) / Revenue (Q: . 20 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 /
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


American Vietnamese Biotech  (HSTC:AMV) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

American Vietnamese Biotech had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage


American Vietnamese Biotech Gross Profit Related Terms

Thank you for viewing the detailed overview of American Vietnamese Biotech's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


American Vietnamese Biotech (HSTC:AMV) Business Description

Traded in Other Exchanges
N/A
Address
20 Road 13, Block DC Song Da, Thu Duc Ward, Ho Chi Minh, VNM
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments and chemicals; producing and trading vaccines and medical biological products; real estate business and financial investment.

American Vietnamese Biotech (HSTC:AMV) Headlines

From GuruFocus

Atlis Motor Vehicles to Present Strategies to Build and Expand Charging Infrastructure

By Stock market mentor Stock market mentor 01-19-2023